Mikart and Nano PharmaSolutions Announce Positive Interim Data from NT-301 Phase 1 Trial and Expansion of NanoTransformer® Manufacturing Capabilities

ATLANTA and SAN DIEGO, Sept. 18, 2025 /PRNewswire/ -- Mikart, LLC, a leading contract development and manufacturing organization (CDMO), and Nano PharmaSolutions, Inc. (NPS), a nanodrug delivery pharmaceutical company, today announced positive safety and pharmacokinetics data from the...